[The role of the echo-dipyridamole test in the diagnosis of coronary disease in patients with associated aortic stenosis].

Ital Heart J Suppl

Servizio di Cardiologia, Ospedale Civile San Camillo Comacchio, AUSL, Ferrara.

Published: January 2000

Background: Coronary vasodilator reserve is often significantly impaired in patients with aortic stenosis by several mechanisms: coronary artery disease, left ventricular hypertrophy, increase in cardiac chamber stiffness. The aim of this study was to evaluate the feasibility and the diagnostic accuracy of the dipyridamole echocardiography test in the diagnosis of coronary artery disease in patients with aortic stenosis.

Methods: Forty patients (26 males, 14 females, mean age 69 +/- 8.9 years) with aortic stenosis (mean valve area 0.7 +/- 0.3 cm2 calculated by the continuity equation) were studied by two-dimensional echocardiography during dipyridamole infusion up to 0.84 mg/kg over 10 min. Wall motion was graded for each segment as normal, hypokinetic, akinetic and dyskinetic. Dipyridamole echocardiography was considered positive for ischemia if wall motion in at least one segment worsened by at least one degree point level compared to wall motion at rest. All patients underwent coronary angiography (mean time after dipyridamole echocardiography 7 +/- 3 days). The chi 2 test and Student's t-test for paired data were used; a p value of < 0.05 was considered as statistically significant.

Results: Only one dipyridamole echocardiography was interrupted because of supraventricular tachycardia appearance. Nine patients showed new asynergy areas during dipyridamole echocardiography; 19 patients had ST segment downsloping of > or = 1 mm during dipyridamole infusion; 12 patients experienced angina during the test. Angiography showed a significant coronary stenosis in 10 patients. Dipyridamole echocardiography sensitivity was 80%, specificity was 96%; specificity of ST segment downsloping and angina were 63 and 76% respectively.

Conclusions: Dipyridamole echocardiography in patients with aortic stenosis is safe and feasible with good sensitivity and better specificity. Our study suggests also that dipyridamole echocardiography test is able to rule out patients with aortic stenosis and coronary artery disease as opposed to those with angina without organic stenosis of the coronary vessels.

Download full-text PDF

Source

Publication Analysis

Top Keywords

dipyridamole echocardiography
32
patients aortic
16
aortic stenosis
16
coronary artery
12
artery disease
12
wall motion
12
patients
11
dipyridamole
10
echocardiography
9
test diagnosis
8

Similar Publications

Article Synopsis
  • Regional wall motion abnormalities (RWMA) can be absent during stress echocardiography in patients with chronic coronary syndromes, even when coronary flow velocity reserve (CFVR) indicates significant disease.
  • A study involving 749 patients showed that those with inducible RWMA had lower CFVR and that 69% underwent coronary revascularization, with 10-year survival rates significantly better in those treated invasively versus conservatively.
  • The findings suggest a physiology-driven approach based on CFVR may be valuable for coronary revascularization decisions in patients with significant left anterior descending coronary artery disease.
View Article and Find Full Text PDF

The role of immune system components in the development of myocardial remodeling in chronic kidney disease (CKD) and kidney transplantation remains an open question. Our aim was to investigate the associations between immune cell subpopulations in the circulation of CKD patients and kidney transplant recipients (KTRs) with subclinical indices of myocardial performance. We enrolled 44 CKD patients and 38 KTRs without established cardiovascular disease.

View Article and Find Full Text PDF

This systematic review investigates the diagnostic and prognostic utility of coronary flow reserve (CFR) assessment through echocardiography in patients with left bundle branch block (LBBB), a condition known to complicate the clinical evaluation of coronary artery disease (CAD). The literature search was performed on PubMed, EMBASE, Web of Science, Scopus, and Google Scholar, was guided by PRISMA standards up to March 2024, and yielded six observational studies that met inclusion criteria. These studies involved a diverse population of patients with LBBB, employing echocardiographic protocols to clarify the impact of LBBB on coronary flow dynamics.

View Article and Find Full Text PDF
Article Synopsis
  • A study analyzed 7576 patients with chronic coronary syndromes to explore the connection between resting coronary flow velocity (CFV) and CFV reserve (CFVR) and their impact on mortality.
  • Researchers found that a resting CFV of 32 cm/s or higher and a CFVR of 2.0 or lower were significant indicators of increased mortality risk.
  • The findings suggest that high resting CFV and low CFVR together contribute to a worse survival rate among patients with a preserved left ventricular ejection fraction.
View Article and Find Full Text PDF
Article Synopsis
  • The Italian Society of Echography and Cardiovascular Imaging (SIECVI) conducted a national survey to investigate stress echocardiography (SE) practices across Italy, collecting data from 228 laboratories in November 2022.
  • The survey revealed that out of 179 centers performing SE, most were located in northern Italy, and the study categorized them into low, moderate, and high volume of activity based on the number of SE examinations.
  • Key findings indicated differences in the use of stressors, with a tendency for high-volume centers to employ multiple stress techniques and incorporate advanced evaluations like coronary flow velocity reserve (CFVR) more frequently than low and moderate volume centers.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!